Annual Total Assets
$101.12 B
+$4.64 B+4.80%
31 December 2023
Summary:
AstraZeneca annual total assets is currently $101.12 billion, with the most recent change of +$4.64 billion (+4.80%) on 31 December 2023. During the last 3 years, it has risen by +$34.39 billion (+51.54%). AZN annual total assets is now -4.03% below its all-time high of $105.36 billion, reached on 31 December 2021.AZN Total Assets Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Total Assets
$104.92 B
+$582.00 M+0.56%
30 September 2024
Summary:
AstraZeneca quarterly total assets is currently $104.92 billion, with the most recent change of +$582.00 million (+0.56%) on 30 September 2024. Over the past year, it has increased by +$8.84 billion (+9.20%). AZN quarterly total assets is now -2.14% below its all-time high of $107.22 billion, reached on 30 September 2021.AZN Quarterly Total Assets Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
AZN Total Assets Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +4.8% | +9.2% |
| 3 y3 years | +51.5% | -2.1% |
| 5 y5 years | +66.7% | +78.1% |
AZN Total Assets High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3 years | -4.0% | +51.5% | -2.1% | +11.4% |
| 5 y | 5 years | -4.0% | +66.7% | -2.1% | +83.4% |
| alltime | all time | -4.0% | +1557.3% | -2.1% | +1333.7% |
AstraZeneca Total Assets History
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2024 | - | $104.92 B(+0.6%) |
| June 2024 | - | $104.34 B(+2.0%) |
| Mar 2024 | - | $102.29 B(+1.2%) |
| Dec 2023 | $101.12 B(+4.8%) | $101.12 B(+5.2%) |
| Sept 2023 | - | $96.09 B(-0.5%) |
| June 2023 | - | $96.54 B(-0.1%) |
| Mar 2023 | - | $96.69 B(+0.2%) |
| Dec 2022 | $96.48 B(-8.4%) | $96.48 B(+2.4%) |
| Sept 2022 | - | $94.19 B(-2.5%) |
| June 2022 | - | $96.58 B(-3.7%) |
| Mar 2022 | - | $100.27 B(-4.8%) |
| Dec 2021 | $105.36 B(+57.9%) | $105.36 B(-1.7%) |
| Sept 2021 | - | $107.22 B(+45.6%) |
| June 2021 | - | $73.64 B(+13.4%) |
| Mar 2021 | - | $64.93 B(-2.7%) |
| Dec 2020 | $66.73 B(+8.7%) | $66.73 B(+4.1%) |
| Sept 2020 | - | $64.11 B(+7.0%) |
| June 2020 | - | $59.93 B(+4.8%) |
| Mar 2020 | - | $57.21 B(-6.8%) |
| Dec 2019 | $61.38 B(+1.2%) | $61.38 B(+4.2%) |
| Sept 2019 | - | $58.91 B(-4.8%) |
| June 2019 | - | $61.89 B(+1.4%) |
| Mar 2019 | - | $61.05 B(+0.7%) |
| Dec 2018 | $60.65 B(-4.3%) | $60.65 B(-1.3%) |
| Sept 2018 | - | $61.44 B(+0.2%) |
| June 2018 | - | $61.34 B(-3.1%) |
| Mar 2018 | - | $63.28 B(-0.1%) |
| Dec 2017 | $63.35 B(+1.3%) | $63.35 B(-1.9%) |
| Sept 2017 | - | $64.59 B(-0.8%) |
| June 2017 | - | $65.12 B(+6.8%) |
| Mar 2017 | - | $60.96 B(-2.5%) |
| Dec 2016 | $62.53 B(+4.1%) | $62.53 B(-1.1%) |
| Sept 2016 | - | $63.22 B(-1.9%) |
| June 2016 | - | $64.42 B(+0.1%) |
| Mar 2016 | - | $64.32 B(+7.1%) |
| Dec 2015 | $60.06 B(+2.5%) | $60.06 B(+11.0%) |
| Sept 2015 | - | $54.12 B(-1.9%) |
| June 2015 | - | $55.17 B(+2.7%) |
| Mar 2015 | - | $53.70 B(-8.4%) |
| Dec 2014 | $58.59 B(+4.8%) | $58.59 B(+4.3%) |
| Sept 2014 | - | $56.16 B(-4.1%) |
| June 2014 | - | $58.54 B(-1.4%) |
| Mar 2014 | - | $59.39 B(+6.2%) |
| Dec 2013 | $55.90 B(+4.4%) | $55.90 B(+3.3%) |
| Sept 2013 | - | $54.12 B(+0.2%) |
| June 2013 | - | $53.99 B(+3.2%) |
| Mar 2013 | - | $52.33 B(-2.3%) |
| Dec 2012 | $53.53 B(+1.3%) | $53.53 B(+2.1%) |
| Sept 2012 | - | $52.45 B(+2.1%) |
| June 2012 | - | $51.39 B(+1.2%) |
| Mar 2012 | - | $50.76 B(-3.9%) |
| Dec 2011 | $52.83 B(-5.9%) | $52.83 B(+0.5%) |
| Sept 2011 | - | $52.58 B(-1.6%) |
| June 2011 | - | $53.41 B(-2.1%) |
| Mar 2011 | - | $54.53 B(-2.8%) |
| Dec 2010 | $56.13 B | $56.13 B(-0.5%) |
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2010 | - | $56.39 B(+3.2%) |
| June 2010 | - | $54.65 B(+1.1%) |
| Mar 2010 | - | $54.08 B(-1.5%) |
| Dec 2009 | $54.92 B(+17.0%) | $54.92 B(+5.8%) |
| Sept 2009 | - | $51.90 B(+3.4%) |
| June 2009 | - | $50.20 B(+7.9%) |
| Mar 2009 | - | $46.52 B(-0.9%) |
| Dec 2008 | $46.95 B(-2.1%) | $46.95 B(-2.6%) |
| Sept 2008 | - | $48.20 B(-4.0%) |
| June 2008 | - | $50.20 B(+3.6%) |
| Mar 2008 | - | $48.46 B(+1.0%) |
| Dec 2007 | $47.96 B(+60.2%) | $47.96 B(+4.4%) |
| Sept 2007 | - | $45.95 B(-3.5%) |
| June 2007 | - | $47.60 B(+61.0%) |
| Mar 2007 | - | $29.57 B(-1.2%) |
| Dec 2006 | $29.93 B(+20.5%) | $29.93 B(+6.4%) |
| Sept 2006 | - | $28.12 B(-1.2%) |
| June 2006 | - | $28.46 B(-4.9%) |
| Mar 2006 | - | $29.93 B(+20.5%) |
| Dec 2005 | $24.84 B(-3.2%) | $24.84 B(+1.3%) |
| Sept 2005 | - | $24.53 B(-1.4%) |
| June 2005 | - | $24.88 B(+0.2%) |
| Mar 2005 | - | $24.84 B(-3.2%) |
| Dec 2004 | $25.65 B(+8.8%) | $25.65 B(+4.8%) |
| Sept 2004 | - | $24.47 B(+0.5%) |
| June 2004 | - | $24.34 B(+2.3%) |
| Mar 2004 | - | $23.79 B(+0.9%) |
| Dec 2003 | $23.57 B(+9.3%) | $23.57 B(+2.3%) |
| Sept 2003 | - | $23.05 B(+3.8%) |
| June 2003 | - | $22.21 B(-1.4%) |
| Mar 2003 | - | $22.53 B(+4.4%) |
| Dec 2002 | $21.58 B(+16.7%) | $21.58 B(+5.1%) |
| Sept 2002 | - | $20.53 B(+1.1%) |
| June 2002 | - | $20.32 B(+1.6%) |
| Mar 2002 | - | $19.99 B(+8.1%) |
| Dec 2001 | $18.50 B(+0.3%) | $18.50 B(-3.2%) |
| Sept 2001 | - | $19.11 B(+3.7%) |
| June 2001 | - | $18.43 B(-3.4%) |
| Mar 2001 | - | $19.07 B(+3.4%) |
| Dec 2000 | $18.45 B(-6.9%) | $18.45 B(-9.6%) |
| Sept 2000 | - | $20.41 B(+2.2%) |
| June 2000 | - | $19.96 B(+8.4%) |
| Mar 2000 | - | $18.41 B(-7.1%) |
| Dec 1999 | $19.82 B(+7.2%) | $19.82 B(-3.7%) |
| Sept 1999 | - | $20.58 B(+4.8%) |
| June 1999 | - | $19.63 B(+6.2%) |
| Dec 1998 | $18.48 B(+123.1%) | $18.48 B(+107.3%) |
| June 1998 | - | $8.91 B(+7.6%) |
| Dec 1997 | $8.28 B(-3.3%) | $8.28 B(-3.3%) |
| Dec 1996 | $8.56 B(+8.8%) | $8.56 B(+8.8%) |
| Dec 1995 | $7.87 B(+7.5%) | $7.87 B(+0.5%) |
| June 1995 | - | $7.83 B(+7.0%) |
| Dec 1994 | $7.32 B(-1.4%) | $7.32 B(-1.4%) |
| Dec 1993 | $7.42 B(+20.0%) | $7.42 B |
| Dec 1992 | $6.19 B(-2.7%) | - |
| Dec 1991 | $6.36 B(+4.3%) | - |
| Dec 1990 | $6.10 B | - |
FAQ
- What is AstraZeneca annual total assets?
- What is the all time high annual total assets for AstraZeneca?
- What is AstraZeneca annual total assets year-on-year change?
- What is AstraZeneca quarterly total assets?
- What is the all time high quarterly total assets for AstraZeneca?
- What is AstraZeneca quarterly total assets year-on-year change?
What is AstraZeneca annual total assets?
The current annual total assets of AZN is $101.12 B
What is the all time high annual total assets for AstraZeneca?
AstraZeneca all-time high annual total assets is $105.36 B
What is AstraZeneca annual total assets year-on-year change?
Over the past year, AZN annual total assets has changed by +$4.64 B (+4.80%)
What is AstraZeneca quarterly total assets?
The current quarterly total assets of AZN is $104.92 B
What is the all time high quarterly total assets for AstraZeneca?
AstraZeneca all-time high quarterly total assets is $107.22 B
What is AstraZeneca quarterly total assets year-on-year change?
Over the past year, AZN quarterly total assets has changed by +$8.84 B (+9.20%)